<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03624816</url>
  </required_header>
  <id_info>
    <org_study_id>43USCH1702</org_study_id>
    <nct_id>NCT03624816</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate the Safety and Efficacy of Restylane Defyne for Chin Augmentation and Correction of Chin Retrusion</brief_title>
  <official_title>A Randomized, No-treatment Controlled, Evaluator-blinded, Multi-center Study to Evaluate the Effectiveness and Safety of Restylane Defyne in the Chin for Augmentation and Correction of Chin Retrusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Q-Med AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Q-Med AB</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To demonstrate the effectiveness of Restylane Defyne for chin augmentation and correction of
      chin retrusion by demonstrating the superiority in responder rates relative to no treatment.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 21, 2018</start_date>
  <completion_date type="Actual">March 13, 2020</completion_date>
  <primary_completion_date type="Actual">March 7, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate effectiveness of the treatment using the Galderma Chin Restrusion Scale</measure>
    <time_frame>12 weeks after last injection</time_frame>
    <description>Effectiveness is defined as change from baseline on the Galderma Chin Retrusion Scale (GCRS; 0=no retrusion, 1=mild retrusion, 2=moderate retrusion, 3=substantial retrusion)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluate subject satisfaction using the FACE-Q</measure>
    <time_frame>12 weeks after last injection</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate effectiveness of the treatment using the Galderma Chin Restrusion</measure>
    <time_frame>24, 36, and 48 weeks after last injection</time_frame>
    <description>Effectiveness is defined as change from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assess overall aesthetic improvement using the Global Aesthetic Improvement Scale</measure>
    <time_frame>12, 24, 36, and 48 weeks after last injection</time_frame>
    <description>determined by response rates</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate subject satisfaction using the FACE-Q</measure>
    <time_frame>24, 36, and 48 weeks after last injection</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate volume change in the treated area using 3D imaging</measure>
    <time_frame>12, 24, 36, and 48 weeks after last injection</time_frame>
    <description>evaluate change from baseline</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">140</enrollment>
  <condition>Chin Retrusion</condition>
  <condition>Chin Augmentation</condition>
  <arm_group>
    <arm_group_label>Restylane Defyne</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>injection with Restylane Defyne</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>no-treatment control</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Restylane Defyne</intervention_name>
    <description>hyaluronic acid dermal filler gel</description>
    <arm_group_label>Restylane Defyne</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects willing to comply with the requirements of the study and providing a signed
             written informed consent.

          -  Males or non-pregnant, non-breastfeeding females, 22 years of age or older, seeking
             chin augmentation or correction of retrusion

        Exclusion Criteria:

          -  Allergy of hypersensitivity to any injectable hyaluronic acid gel or to gram positive
             bacterial proteins

          -  Allergy or hypersensitivity to lidocaine or other amide-type anesthetics, or topical
             anesthetics or nerve blocking agents
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Westside Aesthetics</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90025</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ablon Skin Institute and Research Center</name>
      <address>
        <city>Manhattan Beach</city>
        <state>California</state>
        <zip>90266</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marcus Facial Plastic Surgery</name>
      <address>
        <city>Redondo Beach</city>
        <state>California</state>
        <zip>90277</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Moradi M.D.</name>
      <address>
        <city>Vista</city>
        <state>California</state>
        <zip>92083</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Skin Research Institute, LLC</name>
      <address>
        <city>Coral Gables</city>
        <state>Florida</state>
        <zip>33146</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Etre Cometic Dermatology and Laser Center</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70130</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>WIDLS Chevy Chase</name>
      <address>
        <city>Chevy Chase</city>
        <state>Maryland</state>
        <zip>20815</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maryland Laser Skin and Vein Institute</name>
      <address>
        <city>Hunt Valley</city>
        <state>Maryland</state>
        <zip>21030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Union Square Laser Dermatology</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wilmington Dermatology and Laser Center</name>
      <address>
        <city>Wilmington</city>
        <state>North Carolina</state>
        <zip>28405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dallas Plastic Surgery Institute</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>August 7, 2018</study_first_submitted>
  <study_first_submitted_qc>August 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 10, 2018</study_first_posted>
  <disposition_first_submitted>July 23, 2020</disposition_first_submitted>
  <disposition_first_submitted_qc>July 23, 2020</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">July 27, 2020</disposition_first_posted>
  <last_update_submitted>July 24, 2020</last_update_submitted>
  <last_update_submitted_qc>July 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

